Dr. Kyle - Prognostic Value of the Serum Free Light Chain Ratio in Patients with Newly Diagnosed Myeloma: Proposed Incorporation into the International Staging System.
Robert A. Kyle, MD Mayo Clinic Rochester, Minnesota Chairman, IMF Board of Scientific Advisors
back
print
related articles
Be the first to comment